KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Interest Coverage Ratio: 2010-2025

Historic Interest Coverage Ratio for TherapeuticsMD (TXMD) over the last 6 years, with Sep 2025 value amounting to -287.33.

  • TherapeuticsMD's Interest Coverage Ratio rose 23.99% to -287.33 in Q3 2025 from the same period last year, while for Sep 2025 it was -172.80, marking a year-over-year decrease of 205.43%. This contributed to the annual value of -2.42 for FY2021, which is 55.58% up from last year.
  • TherapeuticsMD's Interest Coverage Ratio amounted to -287.33 in Q3 2025, which was up 17.31% from -347.50 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Interest Coverage Ratio registered a high of -1.24 during Q1 2022, and its lowest value of -435.50 during Q1 2025.
  • Moreover, its 3-year median value for Interest Coverage Ratio was -287.33 (2025), whereas its average is -235.04.
  • In the last 5 years, TherapeuticsMD's Interest Coverage Ratio spiked by 64.80% in 2021 and then slumped by 4,200.62% in 2023.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Interest Coverage Ratio stood at -4.67 in 2021, then spiked by 56.68% to -1.24 in 2022, then crashed by 4,200.62% to -88.65 in 2023, then tumbled by 326.40% to -378.00 in 2024, then climbed by 23.99% to -287.33 in 2025.
  • Its last three reported values are -287.33 in Q3 2025, -347.50 for Q2 2025, and -435.50 during Q1 2025.